U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07284745) titled 'A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism' on Dec. 09.
Brief Summary: The purpose of this study is to assess KarXT + KarX-EC for the treatment of irritability associated with autism in children and adolescents.
Study Start Date: Feb. 27, 2026
Study Type: INTERVENTIONAL
Condition:
Irritability Associated With Autism Spectrum Disorder
Intervention:
DRUG: KarXT
Specified dose on specified days
DRUG: KarX-EC
Specified dose on specified days
DRUG: KarXT + KarX-EC Matching Placebo
Specified dose on specified days
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Bristol-Mye...